Bandaram Pharma Packtech Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 365157,
    "name": "Bandaram Pharma",
    "stock_name": "Bandaram Pharma",
    "full_name": "Bandaram Pharma Packtech Ltd",
    "name_url": "stocks-analysis/bandaram-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "28.10",
    "chg": 0.57,
    "chgp": "2.07%",
    "dir": 1,
    "prev_price": "27.53",
    "mcapval": "51.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524602,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE875N01036",
    "curr_date": "Jun 10, 02:15 PM",
    "curr_time": "14:52 PM",
    "last_traded_at": "Jun 10, 02:15 PM IST",
    "bse_nse_vol": "160 ",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bandaram-pharma-365157-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-4035852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BandaramPharmaP_mojoScore_4035852.png",
        "date": "2026-06-04 10:10:48",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Are Bandaram Pharma Packtech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bandaram-pharma-packtech-ltd-latest-results-good-or-bad-4032394",
        "imagepath": "",
        "date": "2026-06-02 19:29:56",
        "description": "Bandaram Pharma Packtech Ltd's latest financial results for Q4 FY26 highlight a significant disparity between revenue growth and profitability. The company reported net sales of ₹26.26 crores, reflecting a substantial year-on-year increase of 209.31% compared to ₹8.49 crores in Q4 FY25. This impressive revenue growth indicates a strong demand or market share gain; however, it is overshadowed by a notable decline in profitability metrics.\n\nNet profit for the quarter was ₹0.09 crores, which represents a 40.00% decrease from the previous year. This decline is accompanied by a sharp contraction in operating margins, which fell to 3.12% from 6.36% a year earlier. The profit after tax (PAT) margin also diminished to 0.34%, down from 1.77% in Q4 FY25. These figures suggest that while the company is successfully increasing its sales, it is struggling to manage costs effectively, leading to compressed margins and re..."
      },
      {
        "title": "Bandaram Pharma Packtech Q4 FY26: Revenue Surge Masks Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/bandaram-pharma-packtech-q4-fy26-revenue-surge-masks-profitability-concerns-4030834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BandaramPharmaP_quaterlyResult_4030834.png",
        "date": "2026-06-01 21:31:18",
        "description": "Bandaram Pharma Packtech Ltd. (BSE: 524602), a micro-cap healthcare services company with a market capitalisation of ₹52.00 crores, reported a dramatic revenue acceleration in Q4 FY26 that failed to translate into meaningful bottom-line growth. The company posted a consolidated net profit of ₹0.09 crores for the quarter ended March 2026, representing a sharp 52.63% decline quarter-on-quarter and a 40.00% drop year-on-year, even as net sales surged 76.95% sequentially to ₹26.26 crores. Following the results, the stock traded at ₹28.45 on June 1, 2026, reflecting a 5.33% single-day gain but remaining 42.76% below its 52-week high of ₹49.70."
      },
      {
        "title": "When is the next results date for Bandaram Pharma Packtech Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bandaram-pharma-packtech-ltd-4007347",
        "imagepath": "",
        "date": "2026-05-22 23:19:20",
        "description": "The next results date for Bandaram Pharma Packtech Ltd is scheduled for 30 May 2026...."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3998716",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BandaramPharmaP_mojoScore_3998716.png",
        "date": "2026-05-19 10:11:09",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3979420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BandaramPharmaP_mojoScore_3979420.png",
        "date": "2026-05-07 10:11:23",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3963058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BandaramPharmaP_mojoScore_3963058.png",
        "date": "2026-04-26 10:10:24",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3945503",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BandaramPharmaP_mojoScore_3945503.png",
        "date": "2026-04-14 10:10:36",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Bandaram Pharma Packtech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-ltd-is-rated-sell-3930076",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BandaramPharmaP_mojoScore_3930076.png",
        "date": "2026-04-02 10:10:41",
        "description": "Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 149,
    "sid": "365157",
    "stock_news_url": "https://www.marketsmojo.com/news/bandaram-pharma-packtech-365157"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "05-Jun-2026",
      "details": "Resignation of Whole-Time Director of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "29-May-2026",
      "details": "Receipt of Order",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "29-May-2026",
      "details": "Receipt of order",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has declared <strong>1%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has announced <strong>3:1</strong> rights issue, ex-date: 30 Jun 23",
          "dt": "2023-06-30",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Bandaram Pharma Packtech Ltd is Rated Sell

2026-06-04 10:10:48

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Are Bandaram Pharma Packtech Ltd latest results good or bad?

2026-06-02 19:29:56

Bandaram Pharma Packtech Ltd's latest financial results for Q4 FY26 highlight a significant disparity between revenue growth and profitability. The company reported net sales of ₹26.26 crores, reflecting a substantial year-on-year increase of 209.31% compared to ₹8.49 crores in Q4 FY25. This impressive revenue growth indicates a strong demand or market share gain; however, it is overshadowed by a notable decline in profitability metrics. Net profit for the quarter was ₹0.09 crores, which represents a 40.00% decrease from the previous year. This decline is accompanied by a sharp contraction in operating margins, which fell to 3.12% from 6.36% a year earlier. The profit after tax (PAT) margin also diminished to 0.34%, down from 1.77% in Q4 FY25. These figures suggest that while the company is successfully increasing its sales, it is struggling to manage costs effectively, leading to compressed margins and re...

Read full news article

Bandaram Pharma Packtech Q4 FY26: Revenue Surge Masks Profitability Concerns

2026-06-01 21:31:18

Bandaram Pharma Packtech Ltd. (BSE: 524602), a micro-cap healthcare services company with a market capitalisation of ₹52.00 crores, reported a dramatic revenue acceleration in Q4 FY26 that failed to translate into meaningful bottom-line growth. The company posted a consolidated net profit of ₹0.09 crores for the quarter ended March 2026, representing a sharp 52.63% decline quarter-on-quarter and a 40.00% drop year-on-year, even as net sales surged 76.95% sequentially to ₹26.26 crores. Following the results, the stock traded at ₹28.45 on June 1, 2026, reflecting a 5.33% single-day gain but remaining 42.76% below its 52-week high of ₹49.70.

Read full news article

When is the next results date for Bandaram Pharma Packtech Ltd?

2026-05-22 23:19:20

The next results date for Bandaram Pharma Packtech Ltd is scheduled for 30 May 2026....

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-05-19 10:11:09

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-05-07 10:11:23

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-04-26 10:10:24

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-04-14 10:10:36

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date analysis of the company’s standing.

Read full news article

Bandaram Pharma Packtech Ltd is Rated Sell

2026-04-02 10:10:41

Bandaram Pharma Packtech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News